Events and Webinars

IMPORTANT SAFETY INFORMATION

  • SHINGRIX is contraindicated in anyone with a history of a severe allergic reaction (eg, anaphylaxis) to any component of the vaccine or after a previous dose of SHINGRIX
View Prescribing Information

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

Bhumi Pathak, PharmDView Bio >>
January 23, 2018 - 12:15PM CST
Webinar
Please click here to see full prescribing information
  • 1h 30m

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Related Events and Webinars

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

September 18, 2019 7:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
2h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

September 17, 2019 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

August 22, 2019 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
2h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

August 06, 2019 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h 30m

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

July 25, 2019 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
2h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

July 18, 2019 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

July 17, 2019 7:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h 30m

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

July 09, 2019 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

June 20, 2019 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

June 19, 2019 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

June 18, 2019 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

June 13, 2019 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

June 12, 2019 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

June 11, 2019 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h 30m

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

May 15, 2019 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

March 07, 2019 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

February 21, 2019 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h 30m

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

February 20, 2019 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

February 14, 2019 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

February 06, 2019 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

February 05, 2019 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

January 30, 2019 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

January 24, 2019 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

January 22, 2019 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

December 11, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

December 05, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

November 14, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

November 13, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

November 08, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

November 07, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

October 24, 2018 7:00PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

October 24, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

October 18, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
2h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

October 16, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

October 11, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

September 27, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

September 20, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

September 19, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

September 12, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

August 30, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

August 28, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

August 23, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

August 14, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

August 08, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

August 08, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

July 31, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

July 24, 2018 7:00PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

July 24, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

July 19, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

July 18, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

June 28, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

June 27, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

June 21, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

June 14, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

June 13, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

June 07, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

June 06, 2018 7:00PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

June 06, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

June 05, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

May 24, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

May 24, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

May 23, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

May 23, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

May 22, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

May 17, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

May 16, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

May 09, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

May 08, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

May 08, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

May 02, 2018 9:00AM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

April 24, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

April 19, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

April 18, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

April 18, 2018 9:00AM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

April 17, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

April 17, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

April 12, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

April 12, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

April 11, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

April 11, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

April 10, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

April 05, 2018 7:00PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

April 04, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

April 03, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

March 29, 2018 7:00PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

March 29, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

March 27, 2018 7:00PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

March 27, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

March 22, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

March 22, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

March 21, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

March 20, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

March 20, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

March 15, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

March 15, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

March 13, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

March 13, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

March 08, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

March 08, 2018 9:00AM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

March 07, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

March 07, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

March 06, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

March 06, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 22, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 22, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 21, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 21, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 15, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 15, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 15, 2018 9:00AM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 14, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 14, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 14, 2018 9:00AM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 13, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 13, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 08, 2018 7:00PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 08, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 07, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 07, 2018 9:00AM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 06, 2018 7:00PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 06, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

February 06, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 31, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 31, 2018 9:00AM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 30, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 30, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 30, 2018 9:00AM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 25, 2018 7:00PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 25, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 25, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 24, 2018 7:00PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 24, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 24, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 23, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 23, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 18, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 18, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 18, 2018 9:00AM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 17, 2018 12:15PM MST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 17, 2018 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 17, 2018 9:00AM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 16, 2018 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

January 16, 2018 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 20, 2017 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 20, 2017 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 19, 2017 7:00PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 19, 2017 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 19, 2017 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 14, 2017 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 14, 2017 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 13, 2017 7:00PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 13, 2017 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 13, 2017 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 12, 2017 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h 30m

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 12, 2017 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 07, 2017 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 07, 2017 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 06, 2017 12:15PM PST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 06, 2017 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 05, 2017 12:15PM CST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
1h

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved

December 05, 2017 12:15PM EST

GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.

Webinar
2h
< Page 1 >

    IMPORTANT SAFETY INFORMATION

    • SHINGRIX is contraindicated in anyone with a history of a severe allergic reaction (eg, anaphylaxis) to any component of the vaccine or after a previous dose of SHINGRIX
    • Review immunization history for possible vaccine sensitivity and previous vaccination-related adverse reactions. Appropriate medical treatment and supervision must be available to manage possible anaphylactic reactions following administration of SHINGRIX
    • Solicited local adverse reactions in subjects aged 50 years and older were pain (78.0%), redness (38.1%), and swelling (25.9%)
    • Solicited general adverse reactions in subjects aged 50 years and older were myalgia (44.7%), fatigue (44.5%), headache (37.7%), shivering (26.8%), fever (20.5%), and gastrointestinal symptoms (17.3%)
    • SHINGRIX was not studied in pregnant or lactating women, and it is unknown if it is excreted in human milk. Therefore, it cannot be established whether there is vaccine-associated risk with SHINGRIX in pregnant women or if there are effects on breastfed infants or milk production/excretion
    • Vaccination with SHINGRIX may not result in protection of all vaccine recipients

     

    Trademarks are property of their respective owners.

    827007R0 October 2017

    INDICATION

    SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older.

    SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox).

    Chat